Product Code: ETC4471630 | Publication Date: Jul 2023 | Updated Date: Apr 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 |
The United Kingdom`s cardiac marker testing market is experiencing significant growth due to the rising prevalence of cardiovascular diseases and advancements in diagnostic technologies. Cardiac markers, such as troponins, CK-MB, and BNP, play a crucial role in the early detection and management of heart conditions. The market is driven by increasing awareness about heart health, government initiatives to improve healthcare infrastructure, and the growing demand for point-of-care testing. Moreover, the adoption of advanced technologies and the development of new biomarkers are expected to further boost the market growth in the coming years.
The UK cardiac marker testing market is driven by several factors. Firstly, the increasing prevalence of cardiovascular diseases among the aging population is a significant driver. As the population ages, the demand for cardiac marker testing, which aids in early diagnosis and monitoring of heart conditions, continues to rise. Secondly, advancements in medical technology and the introduction of more sensitive and accurate cardiac biomarkers have enhanced the efficiency and reliability of cardiac marker tests, further driving market growth. Additionally, growing awareness among healthcare professionals and patients about the benefits of early detection of cardiac diseases contributes to market expansion.
The UK cardiac marker testing market faces several challenges despite advancements in diagnostic technologies. One significant hurdle is the rising demand for faster and more accurate diagnostic tools amidst healthcare budget constraints. This necessitates continual innovation and adaptation to new regulatory standards, impacting market growth. Additionally, the competitive landscape intensifies as key players strive to maintain market share through strategic partnerships and product differentiation, further influencing pricing dynamics.
The UK government supports the cardiac marker testing market through policies aimed at enhancing healthcare diagnostics. Initiatives such as the NHS Long Term Plan focus on early detection and personalized medicine, which drive the demand for advanced cardiac marker testing. Additionally, regulatory frameworks by bodies like the Medicines and Healthcare products Regulatory Agency (MHRA) ensure the safety and efficacy of diagnostic tests, fostering innovation and adoption in the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Cardiac Marker Testing Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Cardiac Marker Testing Market - Industry Life Cycle |
3.4 United Kingdom (UK) Cardiac Marker Testing Market - Porter's Five Forces |
3.5 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Cardiac Marker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Kingdom (UK) Cardiac Marker Testing Market Trends |
6 United Kingdom (UK) Cardiac Marker Testing Market, By Types |
6.1 United Kingdom (UK) Cardiac Marker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.1.4 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.2 United Kingdom (UK) Cardiac Marker Testing Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F |
6.2.3 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F |
6.2.4 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F |
6.2.5 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F |
6.2.6 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F |
6.2.7 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F |
6.3 United Kingdom (UK) Cardiac Marker Testing Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F |
6.3.3 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F |
6.3.4 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F |
6.3.5 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F |
6.3.6 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F |
6.4 United Kingdom (UK) Cardiac Marker Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F |
6.4.3 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F |
6.4.4 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F |
7 United Kingdom (UK) Cardiac Marker Testing Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Cardiac Marker Testing Market Export to Major Countries |
7.2 United Kingdom (UK) Cardiac Marker Testing Market Imports from Major Countries |
8 United Kingdom (UK) Cardiac Marker Testing Market Key Performance Indicators |
9 United Kingdom (UK) Cardiac Marker Testing Market - Opportunity Assessment |
9.1 United Kingdom (UK) Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 United Kingdom (UK) Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 United Kingdom (UK) Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Cardiac Marker Testing Market - Competitive Landscape |
10.1 United Kingdom (UK) Cardiac Marker Testing Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |